Does the media prefer TRNS or PRE?

In the previous week, Prenetics Global had 7 more articles in the media than Transcat. MarketBeat recorded 12 mentions for Prenetics Global and 5 mentions for Transcat. Prenetics Global's average media sentiment score of 1.04 beat Transcat's score of 0.75 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Prenetics Global 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PRE or CTKB?

In the previous week, Prenetics Global had 10 more articles in the media than Cytek Biosciences. MarketBeat recorded 12 mentions for Prenetics Global and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 1.23 beat Prenetics Global's score of 1.04 indicating that Cytek Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cytek Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer PRE or OPTX?

Prenetics Global presently has a consensus price target of $31.75, suggesting a potential upside of 66.06%. Given Prenetics Global's stronger consensus rating and higher probable upside, research analysts plainly believe Prenetics Global is more favorable than Syntec Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor PRE or OPTX?

In the previous week, Prenetics Global had 9 more articles in the media than Syntec Optics. MarketBeat recorded 12 mentions for Prenetics Global and 3 mentions for Syntec Optics. Prenetics Global's average media sentiment score of 1.04 beat Syntec Optics' score of 0.97 indicating that Prenetics Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Syntec Optics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Prenetics Global (PRE) Competitors

$19.12 +0.54 (+2.91%)

Closing price 04:00 PM Eastern

Extended Trading

$19.18 +0.06 (+0.31%)

As of 05:20 PM Eastern

Compare

PRE vs. EYPT, TRNS, FEIM, CTKB, and OPTX

Should you buy Prenetics Global stock or one of its competitors? MarketBeat compares Prenetics Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Prenetics Global include Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), Frequency Electronics (FEIM), Cytek Biosciences (CTKB), and Syntec Optics (OPTX). These companies are all part of the "measuring and control equipment" industry.

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Prenetics Global (NASDAQ:PRE) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Prenetics Global has a beta of 0.24, indicating that its share price is 76% less volatile than the broader market. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.72, indicating that its share price is 72% more volatile than the broader market.

Prenetics Global currently has a consensus target price of $31.75, suggesting a potential upside of 66.06%. Eyepoint Pharmaceuticals has a consensus target price of $37.83, suggesting a potential upside of 165.03%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.00

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. 5.1% of Eyepoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Prenetics Global had 10 more articles in the media than Eyepoint Pharmaceuticals. MarketBeat recorded 12 mentions for Prenetics Global and 2 mentions for Eyepoint Pharmaceuticals. Prenetics Global's average media sentiment score of 1.04 beat Eyepoint Pharmaceuticals' score of 0.94 indicating that Prenetics Global is being referred to more favorably in the media.

Company	Overall Sentiment
Prenetics Global	Positive
Eyepoint Pharmaceuticals	Positive

Prenetics Global has higher revenue and earnings than Eyepoint Pharmaceuticals. Prenetics Global is trading at a lower price-to-earnings ratio than Eyepoint Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.49	-$37.71M	-$4.58	N/A
Eyepoint Pharmaceuticals	$31.37M	38.15	-$231.96M	-$3.50	N/A

Prenetics Global has a net margin of -62.45% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Prenetics Global's return on equity of -20.33% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%

Summary

Eyepoint Pharmaceuticals beats Prenetics Global on 10 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Transcat?

Transcat (NASDAQ:TRNS) and Prenetics Global (NASDAQ:PRE) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Transcat currently has a consensus target price of $105.33, suggesting a potential upside of 13.54%. Prenetics Global has a consensus target price of $31.75, suggesting a potential upside of 66.06%. Given Prenetics Global's higher possible upside, analysts plainly believe Prenetics Global is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Transcat has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95
Prenetics Global	$92.39M	3.49	-$37.71M	-$4.58	N/A

Transcat has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.24, suggesting that its stock price is 76% less volatile than the broader market.

In the previous week, Prenetics Global had 7 more articles in the media than Transcat. MarketBeat recorded 12 mentions for Prenetics Global and 5 mentions for Transcat. Prenetics Global's average media sentiment score of 1.04 beat Transcat's score of 0.75 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Transcat	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prenetics Global	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

98.3% of Transcat shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 2.8% of Transcat shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Transcat has a net margin of 1.62% compared to Prenetics Global's net margin of -62.45%. Transcat's return on equity of 5.84% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
Prenetics Global	-62.45%	-20.33%	-15.42%

Summary

Transcat beats Prenetics Global on 11 of the 16 factors compared between the two stocks.

How does Prenetics Global compare to Frequency Electronics?

Prenetics Global (NASDAQ:PRE) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Prenetics Global had 11 more articles in the media than Frequency Electronics. MarketBeat recorded 12 mentions for Prenetics Global and 1 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.89 beat Prenetics Global's score of 1.04 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Prenetics Global	Positive
Frequency Electronics	Very Positive

Frequency Electronics has lower revenue, but higher earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.49	-$37.71M	-$4.58	N/A
Frequency Electronics	$69.81M	9.35	$23.69M	$0.75	88.47

Prenetics Global has a beta of 0.24, indicating that its stock price is 76% less volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Frequency Electronics has a net margin of 10.78% compared to Prenetics Global's net margin of -62.45%. Frequency Electronics' return on equity of 12.69% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Frequency Electronics	10.78%	12.69%	7.84%

Prenetics Global presently has a consensus price target of $31.75, indicating a potential upside of 66.06%. Frequency Electronics has a consensus price target of $43.67, indicating a potential downside of 34.19%. Given Prenetics Global's higher possible upside, equities analysts clearly believe Prenetics Global is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Frequency Electronics beats Prenetics Global on 13 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Cytek Biosciences?

Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are owned by institutional investors. 10.4% of Cytek Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Prenetics Global had 10 more articles in the media than Cytek Biosciences. MarketBeat recorded 12 mentions for Prenetics Global and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 1.23 beat Prenetics Global's score of 1.04 indicating that Cytek Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cytek Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Prenetics Global has a beta of 0.24, indicating that its share price is 76% less volatile than the broader market. Comparatively, Cytek Biosciences has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Prenetics Global has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.49	-$37.71M	-$4.58	N/A
Cytek Biosciences	$201.49M	2.84	-$66.54M	-$0.57	N/A

Cytek Biosciences has a net margin of -36.25% compared to Prenetics Global's net margin of -62.45%. Cytek Biosciences' return on equity of -10.07% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Cytek Biosciences	-36.25%	-10.07%	-7.56%

Prenetics Global presently has a consensus price target of $31.75, suggesting a potential upside of 66.06%. Cytek Biosciences has a consensus price target of $5.69, suggesting a potential upside of 28.39%. Given Prenetics Global's stronger consensus rating and higher possible upside, equities research analysts clearly believe Prenetics Global is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Cytek Biosciences beats Prenetics Global on 9 of the 16 factors compared between the two stocks.

How does Prenetics Global compare to Syntec Optics?

Prenetics Global (NASDAQ:PRE) and Syntec Optics (NASDAQ:OPTX) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Syntec Optics has lower revenue, but higher earnings than Prenetics Global. Syntec Optics is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.49	-$37.71M	-$4.58	N/A
Syntec Optics	$28.08M	17.86	-$1.79M	-$0.08	N/A

Prenetics Global has a beta of 0.24, suggesting that its stock price is 76% less volatile than the broader market. Comparatively, Syntec Optics has a beta of -0.82, suggesting that its stock price is 182% less volatile than the broader market.

25.0% of Prenetics Global shares are owned by institutional investors. 0.8% of Syntec Optics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Prenetics Global presently has a consensus price target of $31.75, suggesting a potential upside of 66.06%. Given Prenetics Global's stronger consensus rating and higher probable upside, research analysts plainly believe Prenetics Global is more favorable than Syntec Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Prenetics Global had 9 more articles in the media than Syntec Optics. MarketBeat recorded 12 mentions for Prenetics Global and 3 mentions for Syntec Optics. Prenetics Global's average media sentiment score of 1.04 beat Syntec Optics' score of 0.97 indicating that Prenetics Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Syntec Optics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Syntec Optics has a net margin of -10.95% compared to Prenetics Global's net margin of -62.45%. Prenetics Global's return on equity of -20.33% beat Syntec Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-62.45%	-20.33%	-15.42%
Syntec Optics	-10.95%	-30.86%	-12.35%

Summary

Prenetics Global beats Syntec Optics on 10 of the 16 factors compared between the two stocks.

Get Prenetics Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRE vs. The Competition

Export

Metric	Prenetics Global	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$313.52M	$3.66B	$7.07B	$12.45B
Dividend Yield	N/A	2.20%	2.66%	6.16%
P/E Ratio	-4.17	20.90	27.51	24.87
Price / Sales	3.49	341.80	540.69	102.84
Price / Cash	N/A	143.77	48.53	58.59
Price / Book	2.06	8.75	11.01	6.54
Net Income	-$37.71M	$23.81M	$3.57B	$336.70M
7 Day Performance	-4.02%	3.64%	2.56%	3.31%
1 Month Performance	-9.38%	1.64%	0.89%	1.68%
1 Year Performance	124.41%	69.47%	36.84%	31.96%

Prenetics Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRE Prenetics Global	3.6371 of 5 stars	$19.12 +2.9%	$31.75 +66.1%	+118.8%	$313.52M	$92.39M	N/A	1	Positive News
EYPT Eyepoint Pharmaceuticals	2.9131 of 5 stars	$14.38 +4.7%	$31.80 +121.1%	+46.4%	$1.15B	$31.37M	N/A	120
TRNS Transcat	3.1971 of 5 stars	$89.46 -3.5%	$105.33 +17.7%	+7.6%	$866.35M	$331.88M	154.24	1,413	Analyst Upgrade
FEIM Frequency Electronics	1.2751 of 5 stars	$68.97 -1.1%	$43.67 -36.7%	+165.3%	$686.28M	$69.81M	91.96	200	Positive News
CTKB Cytek Biosciences	2.7945 of 5 stars	$4.07 +5.4%	$5.69 +39.7%	+22.3%	$498.49M	$201.49M	N/A	500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRE) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Prenetics Global (PRE) Competitors

PRE vs. EYPT, TRNS, FEIM, CTKB, and OPTX

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Summary

How does Prenetics Global compare to Transcat?

Summary

How does Prenetics Global compare to Frequency Electronics?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Summary

How does Prenetics Global compare to Syntec Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Prenetics Global (PRE) Competitors

PRE vs. EYPT, TRNS, FEIM, CTKB, and OPTX

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Which has more volatility & risk, PRE or EYPT?

Do analysts rate PRE or EYPT?

Do insiders & institutionals have more ownership in PRE or EYPT?

Does the media refer more to PRE or EYPT?

Which has preferable valuation and earnings, PRE or EYPT?

Is PRE or EYPT more profitable?

Summary

How does Prenetics Global compare to Transcat?

Do analysts recommend TRNS or PRE?

Which has stronger valuation & earnings, TRNS or PRE?

Which has more risk & volatility, TRNS or PRE?

Does the media prefer TRNS or PRE?

Do insiders & institutionals have more ownership in TRNS or PRE?

Is TRNS or PRE more profitable?

Summary

How does Prenetics Global compare to Frequency Electronics?

Does the media favor PRE or FEIM?

Which has preferable valuation and earnings, PRE or FEIM?

Which has more risk & volatility, PRE or FEIM?

Is PRE or FEIM more profitable?

Do analysts rate PRE or FEIM?

Do insiders and institutionals believe in PRE or FEIM?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Do institutionals and insiders hold more shares of PRE or CTKB?

Does the media favor PRE or CTKB?

Which has more risk and volatility, PRE or CTKB?

Which has stronger earnings and valuation, PRE or CTKB?

Is PRE or CTKB more profitable?

Do analysts rate PRE or CTKB?

Summary

How does Prenetics Global compare to Syntec Optics?

Which has higher earnings and valuation, PRE or OPTX?

Which has more volatility and risk, PRE or OPTX?

Do insiders & institutionals have more ownership in PRE or OPTX?

Do analysts prefer PRE or OPTX?

Does the media favor PRE or OPTX?

Is PRE or OPTX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools